[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].
Identifieur interne : 000192 ( Main/Exploration ); précédent : 000191; suivant : 000193[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].
Auteurs : Stéphane Vignot [France] ; Olivier Le Blaye [France] ; Laurence Fluckiger [France] ; Sonia Errard [France] ; Benoît Marin [France] ; Elodie Chapel [France]Source :
- Bulletin du cancer [ 1769-6917 ] ; 2020.
Descripteurs français
- KwdFr :
- Accessibilité des services de santé (MeSH), Agences gouvernementales (organisation et administration), Betacoronavirus (MeSH), Contrôle des maladies transmissibles (législation et jurisprudence), Contrôle des maladies transmissibles (méthodes), Diffusion des innovations (MeSH), Essais cliniques comme sujet (législation et jurisprudence), Essais cliniques comme sujet (organisation et administration), France (MeSH), Guides de bonnes pratiques cliniques comme sujet (MeSH), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Inventions (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Sécurité des patients (MeSH), Traitements en cours d'évaluation (MeSH).
- MESH :
- législation et jurisprudence : Contrôle des maladies transmissibles, Essais cliniques comme sujet.
- méthodes : Contrôle des maladies transmissibles.
- organisation et administration : Agences gouvernementales, Essais cliniques comme sujet.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- Accessibilité des services de santé, Betacoronavirus, Diffusion des innovations, France, Guides de bonnes pratiques cliniques comme sujet, Humains, Inventions, Sécurité des patients, Traitements en cours d'évaluation.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), Clinical Trials as Topic (legislation & jurisprudence), Clinical Trials as Topic (organization & administration), Communicable Disease Control (legislation & jurisprudence), Communicable Disease Control (methods), Coronavirus Infections (prevention & control), Diffusion of Innovation (MeSH), France (MeSH), Government Agencies (organization & administration), Health Services Accessibility (MeSH), Humans (MeSH), Inventions (MeSH), Pandemics (prevention & control), Patient Safety (MeSH), Pneumonia, Viral (prevention & control), Practice Guidelines as Topic (MeSH), Therapies, Investigational (MeSH).
- MESH :
- geographic : France.
- legislation & jurisprudence : Clinical Trials as Topic, Communicable Disease Control.
- methods : Communicable Disease Control.
- organization & administration : Clinical Trials as Topic, Government Agencies.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- Betacoronavirus, Diffusion of Innovation, Health Services Accessibility, Humans, Inventions, Patient Safety, Practice Guidelines as Topic, Therapies, Investigational.
DOI: 10.1016/j.bulcan.2020.04.007
PubMed: 32414537
PubMed Central: PMC7203020
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].</title>
<author><name sortKey="Vignot, Stephane" sort="Vignot, Stephane" uniqKey="Vignot S" first="Stéphane" last="Vignot">Stéphane Vignot</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France. Electronic address: stephane.vignot@ansm.sante.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Le Blaye, Olivier" sort="Le Blaye, Olivier" uniqKey="Le Blaye O" first="Olivier" last="Le Blaye">Olivier Le Blaye</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fluckiger, Laurence" sort="Fluckiger, Laurence" uniqKey="Fluckiger L" first="Laurence" last="Fluckiger">Laurence Fluckiger</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Errard, Sonia" sort="Errard, Sonia" uniqKey="Errard S" first="Sonia" last="Errard">Sonia Errard</name>
<affiliation wicri:level="3"><nlm:affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marin, Benoit" sort="Marin, Benoit" uniqKey="Marin B" first="Benoît" last="Marin">Benoît Marin</name>
<affiliation wicri:level="3"><nlm:affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chapel, Elodie" sort="Chapel, Elodie" uniqKey="Chapel E" first="Elodie" last="Chapel">Elodie Chapel</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32414537</idno>
<idno type="pmid">32414537</idno>
<idno type="doi">10.1016/j.bulcan.2020.04.007</idno>
<idno type="pmc">PMC7203020</idno>
<idno type="wicri:Area/Main/Corpus">001278</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001278</idno>
<idno type="wicri:Area/Main/Curation">001278</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001278</idno>
<idno type="wicri:Area/Main/Exploration">001278</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].</title>
<author><name sortKey="Vignot, Stephane" sort="Vignot, Stephane" uniqKey="Vignot S" first="Stéphane" last="Vignot">Stéphane Vignot</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France. Electronic address: stephane.vignot@ansm.sante.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Le Blaye, Olivier" sort="Le Blaye, Olivier" uniqKey="Le Blaye O" first="Olivier" last="Le Blaye">Olivier Le Blaye</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fluckiger, Laurence" sort="Fluckiger, Laurence" uniqKey="Fluckiger L" first="Laurence" last="Fluckiger">Laurence Fluckiger</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Errard, Sonia" sort="Errard, Sonia" uniqKey="Errard S" first="Sonia" last="Errard">Sonia Errard</name>
<affiliation wicri:level="3"><nlm:affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marin, Benoit" sort="Marin, Benoit" uniqKey="Marin B" first="Benoît" last="Marin">Benoît Marin</name>
<affiliation wicri:level="3"><nlm:affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chapel, Elodie" sort="Chapel, Elodie" uniqKey="Chapel E" first="Elodie" last="Chapel">Elodie Chapel</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Bulletin du cancer</title>
<idno type="eISSN">1769-6917</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term>
<term>Clinical Trials as Topic (legislation & jurisprudence)</term>
<term>Clinical Trials as Topic (organization & administration)</term>
<term>Communicable Disease Control (legislation & jurisprudence)</term>
<term>Communicable Disease Control (methods)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Diffusion of Innovation (MeSH)</term>
<term>France (MeSH)</term>
<term>Government Agencies (organization & administration)</term>
<term>Health Services Accessibility (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Inventions (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Patient Safety (MeSH)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Practice Guidelines as Topic (MeSH)</term>
<term>Therapies, Investigational (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé (MeSH)</term>
<term>Agences gouvernementales (organisation et administration)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Contrôle des maladies transmissibles (législation et jurisprudence)</term>
<term>Contrôle des maladies transmissibles (méthodes)</term>
<term>Diffusion des innovations (MeSH)</term>
<term>Essais cliniques comme sujet (législation et jurisprudence)</term>
<term>Essais cliniques comme sujet (organisation et administration)</term>
<term>France (MeSH)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Inventions (MeSH)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Sécurité des patients (MeSH)</term>
<term>Traitements en cours d'évaluation (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Contrôle des maladies transmissibles</term>
<term>Essais cliniques comme sujet</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Contrôle des maladies transmissibles</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Agences gouvernementales</term>
<term>Essais cliniques comme sujet</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Government Agencies</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Diffusion of Innovation</term>
<term>Health Services Accessibility</term>
<term>Humans</term>
<term>Inventions</term>
<term>Patient Safety</term>
<term>Practice Guidelines as Topic</term>
<term>Therapies, Investigational</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term>
<term>Betacoronavirus</term>
<term>Diffusion des innovations</term>
<term>France</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Inventions</term>
<term>Sécurité des patients</term>
<term>Traitements en cours d'évaluation</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32414537</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1769-6917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>107</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Bulletin du cancer</Title>
<ISOAbbreviation>Bull Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>[Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation].</ArticleTitle>
<Pagination><MedlinePgn>617-619</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0007-4551(20)30205-8</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bulcan.2020.04.007</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vignot</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France. Electronic address: stephane.vignot@ansm.sante.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Le Blaye</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fluckiger</LastName>
<ForeName>Laurence</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Errard</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marin</LastName>
<ForeName>Benoît</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Direction Générale de la Santé (DGS), 14, avenue Duquesne, 75350 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chapel</LastName>
<ForeName>Elodie</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 143-147, boulevard Anatole France, 93285 Saint-Denis cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Essais cliniques en période de pandémie : garantir la sécurité des patients et maintenir l’accès à l’innovation.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Bull Cancer</MedlineTA>
<NlmUniqueID>0072416</NlmUniqueID>
<ISSNLinking>0007-4551</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName>
<QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004059" MajorTopicYN="Y">Diffusion of Innovation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006077" MajorTopicYN="N">Government Agencies</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062069" MajorTopicYN="Y">Inventions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035703" MajorTopicYN="Y">Therapies, Investigational</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32414537</ArticleId>
<ArticleId IdType="pii">S0007-4551(20)30205-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.bulcan.2020.04.007</ArticleId>
<ArticleId IdType="pmc">PMC7203020</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
<li>Saint-Denis (Seine-Saint-Denis)</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Vignot, Stephane" sort="Vignot, Stephane" uniqKey="Vignot S" first="Stéphane" last="Vignot">Stéphane Vignot</name>
</region>
<name sortKey="Chapel, Elodie" sort="Chapel, Elodie" uniqKey="Chapel E" first="Elodie" last="Chapel">Elodie Chapel</name>
<name sortKey="Errard, Sonia" sort="Errard, Sonia" uniqKey="Errard S" first="Sonia" last="Errard">Sonia Errard</name>
<name sortKey="Fluckiger, Laurence" sort="Fluckiger, Laurence" uniqKey="Fluckiger L" first="Laurence" last="Fluckiger">Laurence Fluckiger</name>
<name sortKey="Le Blaye, Olivier" sort="Le Blaye, Olivier" uniqKey="Le Blaye O" first="Olivier" last="Le Blaye">Olivier Le Blaye</name>
<name sortKey="Marin, Benoit" sort="Marin, Benoit" uniqKey="Marin B" first="Benoît" last="Marin">Benoît Marin</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000192 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000192 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32414537 |texte= [Clinical trials during pandemic crisis: How to ensure safety and maintain access to innovation]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32414537" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |